Home > Insider Trading > Latest 13D and 13G Filings > 13G Filing (0001104659-20-021718)

Filing Details

Accession Number:: 0001104659-20-021718
Form Type:: 13G Filing
Publication Date:: 2020-02-14 16:07:48

Filed By:: Venrock Healthcare Capital Partners Ii, L.p.
Company:: Kalvista Pharmaceuticals Inc. (NASDAQ:KALV)
Filing Date:: 2020-02-14
SEC Url:: 13G Filing

Ownership Summary

Please notice the below summary table is generated without human intervention and may contain errors. Please refer to the complete filing displayed below for exact figures.

Name	Shared Voting Power	Shared Dispositive Power	Aggregate Amount Owned Power	Percent of Class
Venrock Healthcare Capital Partners II	986,173	986,173	986,173	5.5%
VHCP Co-Investment Holdings II	986,173	986,173	986,173	5.5%
Venrock Healthcare Capital Partners III	986,173	986,173	986,173	5.5%
VHCP Co-Investment Holdings III	986,173	986,173	986,173	5.5%
VHCP Management II	986,173	986,173	986,173	5.5%
VHCP Management III	986,173	986,173	986,173	5.5%
Shah, Nimish	986,173	986,173	986,173	5.5%
Koh, Bong	986,173	986,173	986,173	5.5%

Filing

	UNITED STATES
	SECURITIES AND EXCHANGE COMMISSION
	Washington, D.C. 20549

SCHEDULE 13G/A

Under the Securities Exchange Act of 1934
(Amendment No. 2)*

KALVISTA PHARMACEUTICALS, INC.

(Name of Issuer)

COMMON STOCK

(Title of Class of Securities)

483497103

(CUSIP Number)

December 31, 2019

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

o	Rule 13d-1(b)
x	Rule 13d-1(c)
o	Rule 13d-1(d)

*The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

CUSIP No. 483497103

	1.	Name of Reporting Persons Venrock Healthcare Capital Partners II, L.P.

	2.	Check the Appropriate Box if a Member of a Group (See Instructions)
		(a)		x(1)
		(b)		o

	3.	SEC Use Only

	4.	Citizenship or Place of Organization Delaware

Number of Shares Beneficially Owned by Each Reporting Person With:			5.		Sole Voting Power 0

			6.		Shared Voting Power 986,173(2)

			7.		Sole Dispositive Power 0

			8.		Shared Dispositive Power 986,173(2)

	9.	Aggregate Amount Beneficially Owned by Each Reporting Person 986,173(2)

	10.	Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) o

	11.	Percent of Class Represented by Amount in Row (9) 5.5%(3)

	12.	Type of Reporting Person (See Instructions) PN

(1)

Venrock Healthcare Capital Partners II, L.P., VHCP Co-Investment Holdings II, LLC, Venrock Healthcare Capital Partners III, L.P., VHCP Co-Investment Holdings III, LLC, VHCP Management II, LLC, VHCP Management III, LLC, Nimish Shah and Bong Koh are members of a group for the purposes of this Schedule 13G/A.

(2)

Consists of 260,646 shares owned by Venrock Healthcare Capital Partners II, L.P., 105,622 shares owned by VHCP Co-Investment Holdings II, LLC, 563,594 shares owned by Venrock Healthcare Capital Partners III, L.P. and 56,311 shares owned by VHCP Co-Investment Holdings III, LLC.

(3)

This percentage is calculated based upon 17,834,126 shares of the Issuer’s common stock outstanding as of November 30, 2019, as reported in the Issuer’s Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on December 3, 2019.

CUSIP No. 483497103

	1.	Name of Reporting Persons VHCP Co-Investment Holdings II, LLC

	2.	Check the Appropriate Box if a Member of a Group (See Instructions)
		(a)		x(1)
		(b)		o

	3.	SEC Use Only

	4.	Citizenship or Place of Organization Delaware

Number of Shares Beneficially Owned by Each Reporting Person With:			5.		Sole Voting Power 0

			6.		Shared Voting Power 986,173(2)

			7.		Sole Dispositive Power 0

			8.		Shared Dispositive Power 986,173(2)

	9.	Aggregate Amount Beneficially Owned by Each Reporting Person 986,173(2)

	10.	Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) o

	11.	Percent of Class Represented by Amount in Row (9) 5.5%(3)

	12.	Type of Reporting Person (See Instructions) OO

(1)

(2)

(3)

CUSIP No. 483497103

	1.	Name of Reporting Persons Venrock Healthcare Capital Partners III, L.P.

	2.	Check the Appropriate Box if a Member of a Group (See Instructions)
		(a)		x(1)
		(b)		o

	3.	SEC Use Only

	4.	Citizenship or Place of Organization Delaware

Number of Shares Beneficially Owned by Each Reporting Person With:			5.		Sole Voting Power 0

			6.		Shared Voting Power 986,173(2)

			7.		Sole Dispositive Power 0

			8.		Shared Dispositive Power 986,173(2)

	9.	Aggregate Amount Beneficially Owned by Each Reporting Person 986,173(2)

	10.	Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) o

	11.	Percent of Class Represented by Amount in Row (9) 5.5%(3)

	12.	Type of Reporting Person (See Instructions) PN

(1)

(2)

(3)

CUSIP No. 483497103

	1.	Name of Reporting Persons VHCP Co-Investment Holdings III, LLC

	2.	Check the Appropriate Box if a Member of a Group (See Instructions)
		(a)		x(1)
		(b)		o

	3.	SEC Use Only

	4.	Citizenship or Place of Organization Delaware

Number of Shares Beneficially Owned by Each Reporting Person With:			5.		Sole Voting Power 0

			6.		Shared Voting Power 986,173(2)

			7.		Sole Dispositive Power 0

			8.		Shared Dispositive Power 986,173(2)

	9.	Aggregate Amount Beneficially Owned by Each Reporting Person 986,173(2)

	10.	Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) o

	11.	Percent of Class Represented by Amount in Row (9) 5.5%(3)

	12.	Type of Reporting Person (See Instructions) OO

(1)

(2)

(3)

CUSIP No. 483497103

	1.	Name of Reporting Persons VHCP Management II, LLC

	2.	Check the Appropriate Box if a Member of a Group (See Instructions)
		(a)		x(1)
		(b)		o

	3.	SEC Use Only

	4.	Citizenship or Place of Organization Delaware

Number of Shares Beneficially Owned by Each Reporting Person With:			5.		Sole Voting Power 0

			6.		Shared Voting Power 986,173(2)

			7.		Sole Dispositive Power 0

			8.		Shared Dispositive Power 986,173(2)

	9.	Aggregate Amount Beneficially Owned by Each Reporting Person 986,173(2)

	10.	Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) o

	11.	Percent of Class Represented by Amount in Row (9) 5.5%(3)

	12.	Type of Reporting Person (See Instructions) OO

(1)

(2)

(3)

CUSIP No. 483497103

	1.	Name of Reporting Persons VHCP Management III, LLC

	2.	Check the Appropriate Box if a Member of a Group (See Instructions)
		(a)		x(1)
		(b)		o

	3.	SEC Use Only

	4.	Citizenship or Place of Organization Delaware

Number of Shares Beneficially Owned by Each Reporting Person With:			5.		Sole Voting Power 0

			6.		Shared Voting Power 986,173(2)

			7.		Sole Dispositive Power 0

			8.		Shared Dispositive Power 986,173(2)

	9.	Aggregate Amount Beneficially Owned by Each Reporting Person 986,173(2)

	10.	Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) o

	11.	Percent of Class Represented by Amount in Row (9) 5.5%(3)

	12.	Type of Reporting Person (See Instructions) OO

(1)

(2)

(3)

CUSIP No. 483497103

	1.	Name of Reporting Persons Shah, Nimish

	2.	Check the Appropriate Box if a Member of a Group (See Instructions)
		(a)		x(1)
		(b)		o

	3.	SEC Use Only

	4.	Citizenship or Place of Organization United States

Number of Shares Beneficially Owned by Each Reporting Person With:			5.		Sole Voting Power 0

			6.		Shared Voting Power 986,173(2)

			7.		Sole Dispositive Power 0

			8.		Shared Dispositive Power 986,173(2)

	9.	Aggregate Amount Beneficially Owned by Each Reporting Person 986,173(2)

	10.	Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) o

	11.	Percent of Class Represented by Amount in Row (9) 5.5%(3)

	12.	Type of Reporting Person (See Instructions) IN

(1)

(2)

(3)

CUSIP No. 483497103

	1.	Name of Reporting Persons Koh, Bong

	2.	Check the Appropriate Box if a Member of a Group (See Instructions)
		(a)		x(1)
		(b)		o

	3.	SEC Use Only

	4.	Citizenship or Place of Organization United States

Number of Shares Beneficially Owned by Each Reporting Person With:			5.		Sole Voting Power 0

			6.		Shared Voting Power 986,173(2)

			7.		Sole Dispositive Power 0

			8.		Shared Dispositive Power 986,173(2)

	9.	Aggregate Amount Beneficially Owned by Each Reporting Person 986,173(2)

	10.	Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) o

	11.	Percent of Class Represented by Amount in Row (9) 5.5%(3)

	12.	Type of Reporting Person (See Instructions) IN

(1)

(2)

(3)

CUSIP No. 483497103

Introductory Note: This Schedule 13G/A is filed on behalf of Venrock Healthcare Capital Partners II, L.P., a limited partnership organized under the laws of the State of Delaware (“VHCP II LP”), VHCP Co-Investment Holdings II, LLC, a limited liability company organized under the laws of the State of Delaware (“VHCP Co-Investment II”), Venrock Healthcare Capital Partners III, L.P., a limited partnership organized under the laws of the State of Delaware (“VHCP III LP”), VHCP Co-Investment Holdings III, LLC, a limited liability company organized under the laws of the State of Delaware (“VHCP Co-Investment III”), VHCP Management II, LLC, a limited liability company organized under the laws of the State of Delaware (“VHCP Management II”), VHCP Management III, LLC, a limited liability company organized under the laws of the State of Delaware (“VHCP Management III” and collectively with VHCP II LP, VHCP Co-Investment II, VHCP III LP, VHCP Co-Investment III and VHCP Management II, the “Venrock Entities”), Nimish Shah (“Shah”) and Bong Koh (“Koh”) in respect of Common Stock of KalVista Pharmaceuticals, Inc.

Item 1.

(a) Name of Issuer

KalVista Pharmaceuticals, Inc.

(b) Address of Issuer’s Principal Executive Offices

55 Cambridge Parkway
Suite 901 East
Cambridge, MA 02142

Item 2.

(a) Name of Person Filing

Venrock Healthcare Capital Partners II, L.P.

VHCP Co-Investment Holdings II, LLC

Venrock Healthcare Capital Partners III, L.P.

VHCP Co-Investment Holdings III, LLC

VHCP Management II, LLC

VHCP Management III, LLC

Nimish Shah

Bong Koh

(b) Address of Principal Business Office or, if none, Residence

New York Office:	Palo Alto Office:
7 Bryant Park	3340 Hillview Avenue
23rd Floor	Palo Alto, CA 94304
New York, NY 10018

All of the Venrock Entities were organized in Delaware. The individuals are both United States citizens.

(d) Title of Class of Securities

Common Stock

(e) CUSIP Number

483497103

CUSIP No. 483497103

Item 3. If this statement is filed pursuant to §§240.13d-1(b), or 240.13d-2(b) or (c), check whether the person filing is a:

Not applicable

Item 4. Ownership

(a) Amount Beneficially Owned as of December 31, 2019:

Venrock Healthcare Capital Partners II, L.P.	986,173	(1)
VHCP Co-Investment Holdings II, LLC	986,173	(1)
Venrock Healthcare Capital Partners III, L.P.	986,173	(1)
VHCP Co-Investment Holdings III, LLC	986,173	(1)
VHCP Management II, LLC	986,173	(1)
VHCP Management III, LLC	986,173	(1)
Nimish Shah	986,173	(1)
Bong Koh	986,173	(1)

(b) Percent of Class as of December 31, 2019:

Venrock Healthcare Capital Partners II, L.P.	5.5	%
VHCP Co-Investment Holdings II, LLC	5.5	%
Venrock Healthcare Capital Partners III, L.P.	5.5	%
VHCP Co-Investment Holdings III, LLC	5.5	%
VHCP Management II, LLC	5.5	%
VHCP Management III, LLC	5.5	%
Nimish Shah	5.5	%
Bong Koh	5.5	%

(i) Sole power to vote or to direct the vote

Venrock Healthcare Capital Partners II, L.P.			0
VHCP Co-Investment Holdings II, LLC			0
Venrock Healthcare Capital Partners III, L.P.			0
VHCP Co-Investment Holdings III, LLC			0
VHCP Management II, LLC			0
VHCP Management III, LLC			0
Nimish Shah			0
Bong Koh			0

CUSIP No. 483497103

(ii) Shared power to vote or to direct the vote

Venrock Healthcare Capital Partners II, L.P.	986,173	(1)
VHCP Co-Investment Holdings II, LLC	986,173	(1)
Venrock Healthcare Capital Partners III, L.P.	986,173	(1)
VHCP Co-Investment Holdings III, LLC	986,173	(1)
VHCP Management II, LLC	986,173	(1)
VHCP Management III, LLC	986,173	(1)
Nimish Shah	986,173	(1)
Bong Koh	986,173	(1)

(iii) Sole power to dispose or to direct the disposition of

Venrock Healthcare Capital Partners II, L.P.			0
VHCP Co-Investment Holdings II, LLC			0
Venrock Healthcare Capital Partners III, L.P.			0
VHCP Co-Investment Holdings III, LLC			0
VHCP Management II, LLC			0
VHCP Management III, LLC			0
Nimish Shah			0
Bong Koh			0

(iv) Shared power to dispose or to direct the disposition of

Venrock Healthcare Capital Partners II, L.P.	986,173	(1)
VHCP Co-Investment Holdings II, LLC	986,173	(1)
Venrock Healthcare Capital Partners III, L.P.	986,173	(1)
VHCP Co-Investment Holdings III, LLC	986,173	(1)
VHCP Management II, LLC	986,173	(1)
VHCP Management III, LLC	986,173	(1)
Nimish Shah	986,173	(1)
Bong Koh	986,173	(1)

(1)

These shares are owned directly as follows: 260,646 shares are owned by Venrock Healthcare Capital Partners II, L.P., 105,622 shares are owned by VHCP Co-Investment Holdings II, LLC, 563,594 shares are owned by Venrock Healthcare Capital Partners III, L.P. and 56,311 shares are owned by VHCP Co-Investment Holdings III, LLC. VHCP Management II, LLC is the general partner of Venrock Healthcare Capital Partners II, L.P. and the manager of VHCP Co-Investment Holdings II, LLC. VHCP Management III, LLC is the general partner of Venrock Healthcare Capital Partners III, L.P. and the manager of VHCP Co-Investment Holdings III, LLC. Messrs. Shah and Koh are the voting members of VHCP Management II, LLC and VHCP Management III, LLC.

Item 5. Ownership of Five Percent or Less of a Class

If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following o.

Item 6. Ownership of More than Five Percent on Behalf of Another Person

Not Applicable

CUSIP No. 483497103

Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company or Control Person.

Not Applicable

Item 8. Identification and Classification of Members of the Group

Not Applicable

Item 9. Notice of Dissolution of a Group

Not Applicable

CUSIP No. 483497103
Item 10.	Certification

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Dated: February 14, 2020

Venrock Healthcare Capital Partners II, L.P.			Venrock Healthcare Capital Partners III, L.P.

By:	VHCP Management II, LLC		By:	VHCP Management III, LLC
Its:	General Partner		Its:	General Partner

By:	/s/ David L. Stepp		By:	/s/ David L. Stepp
	Name:	David L. Stepp		Name:	David L. Stepp
	Its:	Authorized Signatory		Its:	Authorized Signatory

VHCP Co-Investment Holdings II, LLC			VHCP Co-Investment Holdings III, LLC

By:	VHCP Management II, LLC		By:	VHCP Management III, LLC
Its:	Manager		Its:	Manager

By:	/s/ David L. Stepp		By:	/s/ David L. Stepp
	Name:	David L. Stepp		Name:	David L. Stepp
	Its:	Authorized Signatory		Its:	Authorized Signatory

VHCP Management II, LLC			VHCP Management III, LLC

By:	/s/ David L. Stepp		By:	/s/ David L. Stepp
	Name:	David L. Stepp		Name:	David L. Stepp
	Its:	Authorized Signatory		Its:	Authorized Signatory

Nimish Shah			Bong Koh

By:	/s/ David L. Stepp		By:	/s/ David L. Stepp
	David L. Stepp, as attorney-in-fact			David L. Stepp, as attorney-in-fact

CUSIP No. 483497103

EXHIBITS

Joint Filing Agreement (incorporated by reference to Exhibit A to the Schedule 13G filed by the Reporting Persons on August 9, 2018).

Power of Attorney for Nimish Shah (incorporated by reference to Exhibit B to the Schedule 13G filed by the Reporting Persons on August 9, 2018).

Power of Attorney for Bong Koh (incorporated by reference to Exhibit C to the Schedule 13G filed by the Reporting Persons on August 9, 2018).